The store will not work correctly when cookies are disabled.
N'-(4-(Dimethylamino)benzylidene)-6-methylimidazo[2,1-b]thiazole-5-carbohydrazide
ID: ALA3763895
PubChem CID: 127042290
Max Phase: Preclinical
Molecular Formula: C16H17N5OS
Molecular Weight: 327.41
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1nc2sccn2c1C(=O)N/N=C/c1ccc(N(C)C)cc1
Standard InChI: InChI=1S/C16H17N5OS/c1-11-14(21-8-9-23-16(21)18-11)15(22)19-17-10-12-4-6-13(7-5-12)20(2)3/h4-10H,1-3H3,(H,19,22)/b17-10+
Standard InChI Key: YDLMFBKFOKHRNO-LICLKQGHSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
1.7333 -0.7256 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
0.2217 -0.7054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2419 0.7054 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.9876 1.5922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1968 0.6852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9876 -1.5720 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.1968 -0.7054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7333 0.7457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5978 1.9688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0950 3.0584 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.0924 1.8325 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.9585 3.0582 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.3360 -1.0828 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4531 2.9219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.3193 4.1476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.8133 4.0136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.6764 5.2404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.0456 6.6013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.5516 6.7354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.6884 5.5086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.9067 7.8305 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-9.4004 8.9185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-11.1021 7.7253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 2 0
1 5 1 0
6 7 1 0
7 8 2 0
2 6 2 0
3 8 1 0
11 12 1 0
9 10 2 0
9 11 1 0
8 9 1 0
7 13 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
15 20 2 0
21 22 1 0
21 23 1 0
18 21 1 0
12 14 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 327.41 | Molecular Weight (Monoisotopic): 327.1154 | AlogP: 2.53 | #Rotatable Bonds: 4 |
Polar Surface Area: 62.00 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.51 | CX Basic pKa: 4.21 | CX LogP: 1.94 | CX LogD: 1.94 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.59 | Np Likeness Score: -2.60 |
References
1. Samala G, Devi PB, Saxena S, Meda N, Yogeeswari P, Sriram D.. (2016) Design, synthesis and biological evaluation of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors., 24 (6): [PMID:26867485] [10.1016/j.bmc.2016.01.059] |